ClinVar Miner

Submissions for variant NM_021167.5(GATAD1):c.762G>A (p.Gly254=)

gnomAD frequency: 0.00151  dbSNP: rs139637606
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000150716 SCV000168649 benign not specified 2014-03-07 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000150716 SCV000198134 benign not specified 2012-03-19 criteria provided, single submitter clinical testing p.Gly254Gly in Exon 05 of GATAD1: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence and has been identified in 0.3% (24/7020) of E uropean American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs139637606).
Eurofins Ntd Llc (ga) RCV000150716 SCV000231165 likely benign not specified 2014-10-17 criteria provided, single submitter clinical testing
Invitae RCV000233449 SCV000290584 benign Dilated cardiomyopathy 2B 2024-01-28 criteria provided, single submitter clinical testing
Ambry Genetics RCV000620934 SCV000735928 benign Cardiovascular phenotype 2017-07-18 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000233449 SCV000743185 benign Dilated cardiomyopathy 2B 2014-10-10 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000858023 SCV001155134 likely benign not provided 2022-10-01 criteria provided, single submitter clinical testing GATAD1: BP4, BP7
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000233449 SCV002049254 likely benign Dilated cardiomyopathy 2B 2021-03-02 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV000233449 SCV002807112 benign Dilated cardiomyopathy 2B 2021-08-11 criteria provided, single submitter clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000233449 SCV000734586 likely benign Dilated cardiomyopathy 2B no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000858023 SCV001972823 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.